International Immunology Advance Access published online on October 5, 2004
International Immunology, doi:10.1093/intimm/dxh167
© 2004 by The Japanese Society for Immunology
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pathology and Laboratory Medicine, University of British Columbia, BC's Children's Hospital, 4480 Oak Street, Vancouver, British Columbia, V6H 3V4, Canada
* To whom correspondence should be addressed. E-mail: roo{at}interchange.ubc.ca.
Autoimmune (type 1) diabetes mellitus results from the destruction of insulin-producing pancreatic
Accepted August 30, 2004
Article
Progression of spontaneous autoimmune diabetes is associated with a switch in the killing mechanism used by autoreactive CTL
2 Department of Pediatrics, University of British Columbia, BC's Children's Hospital, 4480 Oak Street, Vancouver, British Columbia, V6H 3V4, Canada
3 Department of Medicine, University of British Columbia, BC's Children's Hospital, 4480 Oak Street, Vancouver, British Columbia, V6H 3V4, Canada
4 Department of Microbiology and Infectious Diseases and Julia McFarlane Diabetes Research Centre, Faculty of Medicine, University of Calgary, Health Sciences Centre, 3330 Hospital Drive NW, Calgary, Alberta, T2N 4N1, Canada
![]()
Abstract
-cells by T lymphocytes.
-cell death that is induced by autoreactive CTL in diabetes involves both Fas/Fas ligand (FasL)- and perforin/granzyme-mediated pathways, although their relative contributions during the progression of the disease remain unknown. We demonstrate here that despite the preferential use of the Fas/FasL pathway for cytolysis of
-cell targets, transgenic
-cell-specific CTL were able to kill targets via the perforin pathway when triggered by a higher affinity stimulus. In addition, we show that the killing mechanism used by islet-associated CD8+ T cells from non-obese diabetic mice changed as the mice aged and correspondingly, with the stage of diabetes. These results provide direct evidence for age-related changes in the cytotoxic pathways used by diabetogenic T cells during the progression of autoimmune diabetes.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. L. Dudek, H. E. Thomas, L. Mariana, R. M. Sutherland, J. Allison, E. Estella, E. Angstetra, J. A. Trapani, P. Santamaria, A. M. Lew, et al. Cytotoxic T-Cells From T-Cell Receptor Transgenic NOD8.3 Mice Destroy {beta}-Cells via the Perforin and Fas Pathways Diabetes, September 1, 2006; 55(9): 2412 - 2418. [Abstract] [Full Text] [PDF] |
||||
